Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
2002 10
2003 10
2004 23
2005 22
2006 34
2007 34
2008 33
2009 45
2010 40
2011 77
2012 84
2013 113
2014 107
2015 95
2016 113
2017 152
2018 133
2019 140
2020 164
2021 212
2022 230
2023 228
2024 91

Text availability

Article attribute

Article type

Publication date

Search Results

1,946 results

Results by year

Filters applied: . Clear all
Page 1
Maternal inheritance of glucose intolerance via oocyte TET3 insufficiency.
Chen B, Du YR, Zhu H, Sun ML, Wang C, Cheng Y, Pang H, Ding G, Gao J, Tan Y, Tong X, Lv P, Zhou F, Zhan Q, Xu ZM, Wang L, Luo D, Ye Y, Jin L, Zhang S, Zhu Y, Lin X, Wu Y, Jin L, Zhou Y, Yan C, Sheng J, Flatt PR, Xu GL, Huang H. Chen B, et al. Among authors: zhou f. Nature. 2022 May;605(7911):761-766. doi: 10.1038/s41586-022-04756-4. Epub 2022 May 18. Nature. 2022. PMID: 35585240
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer.
Narayan P, Dilawari A, Osgood C, Feng Z, Bloomquist E, Pierce WF, Jafri S, Kalavar S, Kondratovich M, Jha P, Ghosh S, Tang S, Pazdur R, Beaver JA, Amiri-Kordestani L. Narayan P, et al. Among authors: feng z. J Clin Oncol. 2023 Apr 10;41(11):2108-2116. doi: 10.1200/JCO.22.02447. Epub 2023 Feb 13. J Clin Oncol. 2023. PMID: 36780610 Clinical Trial.
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
Liu X, Dai Q, Ye R, Zi W, Liu Y, Wang H, Zhu W, Ma M, Yin Q, Li M, Fan X, Sun W, Han Y, Lv Q, Liu R, Yang D, Shi Z, Zheng D, Deng X, Wan Y, Wang Z, Geng Y, Chen X, Zhou Z, Liao G, Jin P, Liu Y, Liu X, Zhang M, Zhou F, Shi H, Zhang Y, Guo F, Yin C, Niu G, Zhang M, Cai X, Zhu Q, Chen Z, Liang Y, Li B, Lin M, Wang W, Xu H, Fu X, Liu W, Tian X, Gong Z, Shi H, Wang C, Lv P, Tao Z, Zhu L, Yang S, Hu W, Jiang P, Liebeskind DS, Pereira VM, Leung T, Yan B, Davis S, Xu G, Nogueira RG; BEST Trial Investigators. Liu X, et al. Among authors: zhou f. Lancet Neurol. 2020 Feb;19(2):115-122. doi: 10.1016/S1474-4422(19)30395-3. Epub 2019 Dec 9. Lancet Neurol. 2020. PMID: 31831388 Clinical Trial.
Shear-Stable Polymer Brush Surfaces.
Liu Y, Wu Y, Zhou F. Liu Y, et al. Among authors: zhou f. Langmuir. 2023 Jan 10;39(1):37-44. doi: 10.1021/acs.langmuir.2c03012. Epub 2022 Dec 22. Langmuir. 2023. PMID: 36546609 Review.
Transport and inhibition mechanisms of human VMAT2.
Wu D, Chen Q, Yu Z, Huang B, Zhao J, Wang Y, Su J, Zhou F, Yan R, Li N, Zhao Y, Jiang D. Wu D, et al. Among authors: zhou f. Nature. 2024 Feb;626(7998):427-434. doi: 10.1038/s41586-023-06926-4. Epub 2023 Dec 11. Nature. 2024. PMID: 38081299
1,946 results